تخطي إلى التنقل الرئيسي تخطي إلى البحث تخطي إلى المحتوى الرئيسي

Development platform for artificial pancreas algorithms

  • Mohamed Raef Smaoui*
  • , Remi Rabasa-Lhoret
  • , Ahmad Haidar
  • *المؤلف المقابل لهذا العمل
  • Nutrition Department
  • University of Montreal
  • McGill University

نتاج البحث: Article › مراجعة النظراء

12 اقتباسات (Scopus)

ملخص

Background and aims Assessing algorithms of artificial pancreas systems is critical in developing automated and fault-tolerant solutions that work outside clinical settings. The development and evaluation of algorithms can be facilitated with a platform that conducts virtual clinical trials. We present in this paper a clinically validated cloud-based distributed platform that supports the development and comprehensive testing of single and dual-hormone algorithms for type 1 diabetes mellitus (T1DM). Methods The platform is built on principles of object-oriented design and runs user algorithms in realtime virtual clinical trials utilizing a multi-threaded environment enabled by concurrent execution over a cloud infrastructure. The platform architecture isolates user algorithms located on personal machines from proprietary patient data running on the cloud. Users import a plugin into their algorithms (Matlab, Python, or Java) to connect to the platform. Once connected, users interact with a graphical interface to design experimental protocols for their trials. Protocols include trial duration in days, mealtimes and amounts, variability in mealtimes and amounts, carbohydrate counting errors, snacks, and onboard insulin levels. Results The platform facilitates development by solving the ODE model in the cloud on large CPUoptimized machines, providing a 62% improvement in memory, speed and CPU utilization. Users can easily debug & modify code, test multiple strategies, and generate detailed clinical performance reports. We validated and integrated into the platform a glucoregulatory system of ordinary differential equations (ODEs) parameterized with clinical data to mimic the inter and intra-day variability of glucose responses of 15 T1DM patients. Conclusion The platform utilizes the validated patient model to conduct virtual clinical trials for the rapid development and testing of closed-loop algorithms for T1DM.

اللغة الأصليةEnglish
رقم المقالe0243139
دوريةPLoS ONE
مستوى الصوت15
رقم الإصدار12 December
المعرِّفات الرقمية للأشياء
حالة النشرPublished - ديسمبر 2020

أهداف الأمم المتحدة للتنمية المستدامة

يساهم هذا المخرج في تحقيق أهداف الأمم المتحدة للتنمية المستدامة التالية (SDGs)

  1. Good health and well being
    Good health and well being

بصمة

أدرس بدقة موضوعات البحث “Development platform for artificial pancreas algorithms'. فهما يشكلان معًا بصمة فريدة.

قم بذكر هذا